Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-08

Clinical Trial Update: A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS [Phase 3]

View source ↗

Summary

A completed Phase 3 feasibility trial evaluating glibenclamide and metformin versus standard care in gestational diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glibenclamide (glibenclamide)
  • metformin (metformin)

Snippet

Sponsor: University of Edinburgh | Conditions: Pregnancy, Gestational Diabetes | Phase 3 | Status: COMPLETED